Drug-related deaths in hospital inpatients: A retrospective cohort study
- PMID: 29148077
- PMCID: PMC5809345
- DOI: 10.1111/bcp.13471
Drug-related deaths in hospital inpatients: A retrospective cohort study
Abstract
Aims: To determine the incidence of drug-related deaths (DRD) in a university hospital in 2015, to describe their characteristics, and to discover risk factors of DRD.
Methods: An analytic and retrospective cohort study. Patients with a death diagnosed predefined from a list of medical conditions potentially caused by drugs were the selected cases for further review. Causality assessment was evaluated by a local drug safety committee.
Results: Out of 1135 inpatient deaths, 73 DRD were included (six were hospital-acquired). The incidence of DRD of all hospital admissions was 0.34%, and the incidence of all deaths cases was 7%. Drugs were the cause of death in 38 patients (52%) and a contributive role in 35 (48%). The median age of DRD patients was 72 years (range 19-94) and 72.6% were men. The median hospital stay, Charlson score and number of drugs were 5 days, 2 points and seven drugs respectively. The most frequent DRD were cerebral haemorrhages and infections in drug-immunosuppressed patients (32, 43.8%, each group). The most frequently involved drugs were antineoplastics and glucocorticosteroids (40% and 18%), and antithrombotics (33%); drug-drug interactions were present in 44% DRD. Sex, age and number of drugs were risk factors of DRD.
Conclusions: Adverse drug reactions were a significant cause of death in hospitalized patients, mainly haemorrhages and infections precipitated by drug-drug interactions. Risk factors for DRD were sex, age and number of drugs. Preventable DRD and measures to avoid them should be accurately assessed in further studies.
Keywords: adverse drug reaction; epidemiology; hospital mortality; incidence.
© 2017 The British Pharmacological Society.
Similar articles
-
Drug-related mortality among inpatients: a retrospective observational study.Eur J Clin Pharmacol. 2016 Jun;72(6):731-6. doi: 10.1007/s00228-016-2026-0. Epub 2016 Feb 20. Eur J Clin Pharmacol. 2016. PMID: 26896941
-
Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine.Br J Clin Pharmacol. 2000 Feb;49(2):158-67. doi: 10.1046/j.1365-2125.2000.00132.x. Br J Clin Pharmacol. 2000. PMID: 10671911 Free PMC article.
-
Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands.Drug Saf. 2010 Oct 1;33(10):853-64. doi: 10.2165/11536800-000000000-00000. Drug Saf. 2010. PMID: 20812770
-
Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults.Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1510-8. doi: 10.2215/CJN.02140215. Epub 2015 Jul 31. Clin J Am Soc Nephrol. 2015. PMID: 26231194 Free PMC article.
-
Association of preventable adverse drug events with inpatients' length of stay-A propensity-matched cohort study.Int J Clin Pract. 2017 Oct;71(10). doi: 10.1111/ijcp.12990. Epub 2017 Sep 5. Int J Clin Pract. 2017. PMID: 28873271
Cited by
-
Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study.J Clin Med. 2021 Sep 8;10(18):4053. doi: 10.3390/jcm10184053. J Clin Med. 2021. PMID: 34575164 Free PMC article.
-
Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.Eur J Clin Pharmacol. 2021 Oct;77(10):1443-1452. doi: 10.1007/s00228-021-03131-y. Epub 2021 Apr 7. Eur J Clin Pharmacol. 2021. PMID: 33829295 Review.
-
Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies.Cells. 2019 May 17;8(5):476. doi: 10.3390/cells8050476. Cells. 2019. PMID: 31109006 Free PMC article. Review.
-
Self-administration of medication: a pragmatic randomized controlled trial of the impact on dispensing errors, perceptions, and satisfaction.Ther Adv Drug Saf. 2020 May 4;11:2042098620904616. doi: 10.1177/2042098620904616. eCollection 2020. Ther Adv Drug Saf. 2020. PMID: 32435443 Free PMC article.
-
Application of a molecular networking approach using LC-HRMS combined with the MetWork webserver for clinical and forensic toxicology.Heliyon. 2024 Aug 31;10(17):e36735. doi: 10.1016/j.heliyon.2024.e36735. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286100 Free PMC article.
References
-
- Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011; 45: 977–989. - PubMed
-
- Starfield B. Is US health really the best in the world? JAMA 2000; 284: 483–485. - PubMed
-
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta‐analysis of prospective studies. JAMA 1998; 279: 1200–1205. - PubMed
-
- Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017–1025. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical